Abstract
A prospective, randomized, double-blind, comparative clinical study of efficacy and safety of a biosimilar adalimumab with innovator product in patients with active rheumatoid arthritis on a stable dose of methotrexate
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have